1-3 of 3
Megan Breeden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy

Brief Report
Elias Jabbour, Hagop Kantarjian, Dan Jones, Megan Breeden, Guillermo Garcia-Manero, Susan O'Brien, Farhad Ravandi, Gautam Borthakur, Jorge Cortes
Journal: Blood
Blood (2008) 112 (1): 53–55.
https://doi.org/10.1182/blood-2007-11-123950
Published: 2008
Journal Articles

Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors

Jorge Cortes, Elias Jabbour, Hagop Kantarjian, C. Cameron Yin, Jianqin Shan, Susan O'Brien, Guillermo Garcia-Manero, Francis Giles, Megan Breeden, Nubia Reeves, William G. Wierda, Dan Jones
Journal: Blood
Blood (2007) 110 (12): 4005–4011.
https://doi.org/10.1182/blood-2007-03-080838
Published: 2007
Journal Articles

Kinase Domain Point Mutations in Ph+ Acute Lymphoblastic Leukemia (ALL) and Lymphoid Blast Crisis of Chronic Myeloid Leukemia (CML) and Their Emergence Following Therapy with Bcr-Abl Kinase Inhibitors.

Dan Jones, MD, PhD, Rayjalakshmi Luthra, PhD, Hagop M. Kantarjian, MD, Megan Breeden, BS, Susan O’Brien, MD, Stefan Faderl, MD, Jorge Cortes, MD, Deborah Thomas, MD
Journal: Blood
Blood (2006) 108 (11): 1831.
https://doi.org/10.1182/blood.V108.11.1831.1831
Published: 2006